CEO of Cytura is Dr Ad van Gorp

He is the founder and former CEO of Dutch Lead Pharma and was member of Kiadis Pharma management team.

Van Gorp is skilled in Physiology, Pharmacology, Biotechnology and Drug Development. He is a strong entrepreneurial professional graduated from University of Utrecht and obtained his PhD from the university of Maastricht.

In close collaboration with Centre for Drug Design and Discovery (CD3) of the KU Leuven and  Amsterdam UMC, Van Gorp aspires to advance Cytura’s innovative first-in-class therapies targeting genomic instability of cancers.

Ad van Gorp

Latest news

We will keep you updated on our progress

Cytura’s unique approach

Making cancer treatment more effective world wide improve patients lives


We’ll keep you updated on any relevant events where we can meet